Kingsbridge Capital

Total investments

5

Average round size

31M

Portfolio companies

5

Rounds per year

0.28

Lead investments

1

Exits

2

Stages of investment
Private Equity
Areas of investment
BiotechnologyHealth CareManufacturingMedicalChildrenPharmaceuticalTherapeuticsBiopharmaTextiles

Summary

Kingsbridge Capital is the famous VC, which was founded in 2003. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2016. The important activity for fund was in 2005. This Kingsbridge Capital works on 46 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.

Besides them, we counted 1 critical employee of this fund in our database.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Tercica, Kosan Biosciences, Soligenix. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Textiles, Pharmaceutical.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Kingsbridge Capital, startups are often financed by Rho Ventures, Prospect Venture Partners, MedImmune Ventures. The meaningful sponsors for the fund in investment in the same round are Rosalind Capital Partners, Rockmore Capital, OpusPoint Partners. In the next rounds fund is usually obtained by Third Security, GenenFUND.

Show more

Investments analytics

Analytics

Total investments
5
Lead investments
1
Exits
2
Rounds per year
0.28
Investments by industry
  • Biotechnology (4)
  • Health Care (2)
  • Pharmaceutical (2)
  • Medical (1)
  • Biopharma (1)
  • Show 4 more
Investments by region
  • United States (4)
  • Germany (1)
Peak activity year
2005
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
39
Avg. valuation at time of investment
44M
Group Appearance index
0.20
Avg. company exit year
13
Avg. multiplicator
63.33
Strategy success index
0.33

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.